Antiobesity Effects of Lactobacillus paracasei Subsp. paracasei , L. casei 431 on High-Fat Diet-Induced Obese Rats
Journal of Medicinal Food · 01.07.2023 · 26 (7) · 445-453
DOI: 10.1089/jmf.2022.k.0144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Food, erschienen am 01.07.2023. Verfasst von Yun Jeong Shin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Functional Food Evaluation Team, Technical Assistance Department, The Food Industry Promotional Agency of Korea, Iksan, Korea. Hauptthemen laut MEDLINE: Lactobacillus, Probiotics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Obesity is currently regarded as a global concern, and the key objectives of the global health strategy include its prevention and control. Probiotic supplementation can help achieve these objectives. This study aimed to assess whether a probiotic strain Lactobacillus paracasei ssp. paracasei, Lactobacillus casei 431 (henceforth, L. casei 431) possesses antiobesogenic properties. High-fat diet-induced obese Sprague-Dawley rats were treated with L. casei 431 for 10 weeks, and the outcomes were compared with those of rats treated with the antiobesity medication orlistat. Body weights, epididymal fat, and tissues from mice were assessed. Furthermore, serological and histological analyses were performed. Epididymal fat accumulation was significantly reduced in groups administered L. casei 431 and orlistat. Furthermore, L. casei 431 and orlistat treatments lowered serum alanine transaminase, aspartate aminotransferase, and triglyceride (TG) levels. Hematoxylin and eosin staining of the liver and epididymal adipose tissues showed that the L. casei 431-treated groups exhibited reduced lipid buildup and adipocyte size. Furthermore, sterol regulatory element-binding protein 1c, adipose TG lipase, and lipoprotein lipase messenger RNA (mRNA) levels were upregulated, leading to lipid oxidation and degradation, in L. casei 431-supplemented groups. Furthermore, carnitine palmitoyltransferase 1, a major factor in lipolysis, was consistently upregulated at the protein level after L. casei 431 administration. Collectively, these results demonstrate the potential of L. casei 431 in alleviating obesity in rats through optimizing lipid metabolism and some related biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Functional Food Evaluation Team, Technical Assistance Department, The Food Industry Promotional Agency of Korea, Iksan, Korea.
- Department of Food Science, Human Nutrition and Obesity Research Center, Jeonbuk National University, Jeonju, Korea.
- VIXXOL Corporation, Gunpo, Korea.
ORCID-Profile: Yun Jeong Shin, Hye-Rin Cho, Patience Mahoro, Min-Jung Bae
Zitieren
APA
Shin, Y. J., Bae, J. M., Cho, H. R., Mahoro, P., Kim, H. H., Kim, S. H., Kim, T. H., & Bae, M. J. (2023). Antiobesity Effects of Lactobacillus paracasei Subsp. paracasei , L. casei 431 on High-Fat Diet-Induced Obese Rats. Journal of Medicinal Food, 26(7), 445-453. https://doi.org/10.1089/jmf.2022.k.0144
Vancouver
Shin YJ, Bae JM, Cho HR, Mahoro P, Kim HH, Kim SH, et al. Antiobesity Effects of Lactobacillus paracasei Subsp. paracasei , L. casei 431 on High-Fat Diet-Induced Obese Rats. Journal of Medicinal Food. 2023;26(7):445-453. doi:10.1089/jmf.2022.k.0144
BibTeX
@article{Shin2023,
author = {Shin, Yun Jeong and Bae, Jung-Min and Cho, Hye-Rin and Mahoro, Patience and Kim, Hye Hyun and Kim, Seon Hwa and Kim, Tae Hoon and Bae, Min-Jung},
title = {Antiobesity Effects of Lactobacillus paracasei Subsp. paracasei , L. casei 431 on High-Fat Diet-Induced Obese Rats},
journal = {Journal of Medicinal Food},
year = {2023},
volume = {26},
number = {7},
pages = {445--453},
doi = {10.1089/jmf.2022.k.0144}
}
EUVIMED